Sulphonamides and Sulfones PDF

Download now Report

Download Sulphonamides and Sulfones PDF Notes

Access comprehensive PDF notes on Sulphonamides and Sulfones. These notes provide in-depth information about these two important classes of antimicrobial agents, detailing their mechanisms of action, pharmacological properties, clinical applications (including the specific uses of sulfones like dapsone in leprosy), and potential adverse effects. This resource is invaluable for students of pharmacology, medicine, microbiology, and healthcare professionals seeking to understand these drugs. You can download the "Sulphonamides and Sulfones" PDF notes for free for offline study or view them directly online. Slides By DuloMix is committed to offering high-quality educational materials like these to support your learning journey.

Keywords: Sulphonamides, Sulfones, Dapsone, antimicrobial PDF, antibacterial notes, folate inhibitors, leprosy treatment, PABA antagonists, pharmacology study material, free PDF download, DuloMix slides.

Why Download Sulphonamides and Sulfones Notes from Slides By DuloMix?

• Detailed Coverage: Thorough exploration of both sulphonamides and sulfones, highlighting their similarities and differences.
• High-Quality Content: Accurate and well-organized information essential for academic and clinical understanding.
• Free Access: All materials, including these specialized notes on Sulphonamides and Sulfones, are available completely free of charge.
• Easy Download & Online Viewing: Convenient one-click download for offline access and an online viewer to preview the PDF directly.
• Essential for Medical Studies: Crucial for understanding the treatment of various bacterial infections and specific conditions like leprosy and Pneumocystis pneumonia.

Enhance your knowledge of these vital antimicrobial agents. Click the download button to get your copy of the "Sulphonamides and Sulfones" PDF notes now, or view them online for free!

Understanding Sulphonamides and Sulfones: Antimicrobial Agents

The notes on "Sulphonamides and Sulfones" delve into two distinct but mechanistically related classes of synthetic antimicrobial agents. Both groups interfere with folic acid synthesis in susceptible microorganisms, a pathway crucial for their growth and replication. While sulphonamides have a broader historical application, sulfones, particularly dapsone, are renowned for their role in treating leprosy and other specific conditions.

I. Sulphonamides

Sulphonamides were the first effective systemic antibacterial agents discovered, heralding the era of antimicrobial chemotherapy.

A. Mechanism of Action

• Competitive Antagonism of PABA: Sulphonamides are structural analogues of para-aminobenzoic acid (PABA). They competitively inhibit the bacterial enzyme dihydropteroate synthetase, which is essential for incorporating PABA into dihydropteroic acid, a precursor of folic acid.
• Bacteriostatic Effect: By blocking folic acid synthesis, sulphonamides prevent bacteria from producing purines and thymidine, which are necessary for DNA and RNA synthesis. This inhibits bacterial growth and multiplication, allowing the host's immune system to clear the infection.
• Selective Toxicity: Mammalian cells utilize preformed folic acid from the diet and do not synthesize it, making them insusceptible to the action of sulphonamides.

B. Pharmacological Properties

• Spectrum of Activity: Broad spectrum, initially active against many Gram-positive and Gram-negative bacteria, Chlamydia, Nocardia, Actinomyces, and some protozoa like Toxoplasma and Plasmodium. However, widespread resistance has significantly limited their utility as single agents.
• Classification:
  • Oral Absorbable Agents:
    • Short-acting: Sulfisoxazole, Sulfadiazine.
    • Intermediate-acting: Sulfamethoxazole (a component of co-trimoxazole).
    • Long-acting: Sulfadoxine (used with pyrimethamine for malaria).
  • Oral Non-absorbable Agents: Sulfasalazine (used in inflammatory bowel disease, cleaved in the colon to 5-aminosalicylic acid and sulfapyridine).
  • Topical Agents: Silver sulfadiazine (burns), Sodium sulfacetamide (ophthalmic infections), Mafenide (burns).
• Pharmacokinetics: Variable absorption, distribution (including CNS and across placenta), hepatic metabolism (acetylation, glucuronidation), and renal excretion. Acetylated metabolites can be less soluble and may cause crystalluria.

C. Therapeutic Uses

• Urinary tract infections (often as co-trimoxazole).
• Nocardiosis.
• Toxoplasmosis (with pyrimethamine).
• Prevention of infections in burn patients (topical).
• Inflammatory bowel disease (Sulfasalazine).

D. Adverse Effects

• Hypersensitivity reactions: Rashes, fever, photosensitivity, Stevens-Johnson syndrome (rare but severe).
• Hematological effects: Hemolytic anemia (in G6PD deficient individuals), agranulocytosis, aplastic anemia.
• Renal toxicity: Crystalluria, hematuria, obstruction (minimized by adequate hydration and urine alkalinization).
• Kernicterus: In newborns, due to displacement of bilirubin from albumin. Contraindicated in neonates and late pregnancy.
• Drug Interactions: Potentiate effects of warfarin, sulfonylureas, phenytoin.

II. Sulfones

Sulfones are chemically distinct from sulphonamides but share a similar primary mechanism of action involving PABA antagonism. The principal drug in this class is Dapsone (diaminodiphenyl sulfone, DDS).

A. Dapsone: The Prototypical Sulfone

1. Mechanism of Action:

• Similar to sulphonamides, Dapsone competitively inhibits dihydropteroate synthetase, thereby blocking folic acid synthesis in susceptible organisms like Mycobacterium leprae.
• It is considered bacteriostatic for M. leprae.
• Dapsone also possesses anti-inflammatory properties, possibly by inhibiting neutrophil myeloperoxidase and generation of reactive oxygen species, which contributes to its efficacy in certain dermatological conditions.

2. Pharmacological Properties:

• Spectrum of Activity: Primarily known for its activity against Mycobacterium leprae. Also active against Pneumocystis jirovecii, Toxoplasma gondii, and has some activity against malaria parasites.
• Pharmacokinetics: Well absorbed orally, widely distributed in body tissues including skin. Undergoes N-acetylation (genetically determined fast/slow acetylators) and N-hydroxylation (to a metabolite responsible for some toxicity). Long half-life (20-30 hours), allowing for daily or less frequent dosing in some regimens. Excreted primarily in urine after hepatic metabolism. Enterohepatic circulation occurs.

3. Therapeutic Uses:

• Leprosy (Hansen's Disease): A cornerstone of multi-drug therapy (MDT) for all forms of leprosy, typically in combination with rifampicin and clofazimine, to prevent resistance.
• Dermatitis Herpetiformis: A chronic, intensely itchy blistering skin disease; dapsone provides rapid relief.
• Prophylaxis and Treatment of Pneumocystis jirovecii Pneumonia (PCP): An alternative for patients who cannot tolerate co-trimoxazole. Often used in combination with trimethoprim or pyrimethamine.
• Other uses: Prophylaxis of toxoplasmosis in immunocompromised patients, malaria prophylaxis/treatment (in combination), and various inflammatory skin conditions like bullous pemphigoid, lupus erythematosus (cutaneous forms), and vasculitis.

4. Adverse Effects:

• Hematological: Hemolysis (dose-related, more severe in G6PD deficiency), methemoglobinemia (can cause cyanosis). Regular blood monitoring is often necessary. Agranulocytosis is rare but serious.
• Gastrointestinal: Nausea, vomiting, abdominal pain.
• Dermatological: Rashes, exfoliative dermatitis. Photosensitivity.
• Neurological: Peripheral neuropathy (usually motor, dose-related and reversible). Headache, insomnia.
• Hepatic: Hepatitis, cholestatic jaundice (rare).
• "Dapsone Hypersensitivity Syndrome" or "Sulfone Syndrome": A rare but potentially fatal idiosyncratic reaction occurring 2-6 weeks after starting therapy, characterized by fever, rash, lymphadenopathy, hepatitis, and sometimes other organ involvement. Requires immediate discontinuation of the drug.

Comparison and Key Differences

While both sulphonamides and sulfones inhibit folate synthesis:

• Chemical Structure: Sulfones (R-SO₂-R') differ from sulphonamides (R-SO₂-NH-R').
• Primary Clinical Niche: Sulphonamides (often as co-trimoxazole) have broader bacterial infection applications (though declining due to resistance), while dapsone is indispensable for leprosy and specific dermatological/protozoal conditions.
• Toxicity Profile: Both can cause hypersensitivity and hematological issues. Dapsone has a more pronounced risk of hemolysis and methemoglobinemia, and the specific Dapsone Hypersensitivity Syndrome.

Understanding the pharmacology of sulphonamides and sulfones is essential for their appropriate and safe use in treating a range of infectious and inflammatory diseases. These notes provide a foundational overview of these important drug classes.

Info!
If you are the copyright owner of this document and want to report it, please visit the copyright infringement notice page to submit a report.